BG105776A - Microbiological method for the preparation of pseudomonic acid a antibiotic - Google Patents

Microbiological method for the preparation of pseudomonic acid a antibiotic

Info

Publication number
BG105776A
BG105776A BG105776A BG10577601A BG105776A BG 105776 A BG105776 A BG 105776A BG 105776 A BG105776 A BG 105776A BG 10577601 A BG10577601 A BG 10577601A BG 105776 A BG105776 A BG 105776A
Authority
BG
Bulgaria
Prior art keywords
pseudomonic acid
preparation
pseudomonas
degrees
procedure
Prior art date
Application number
BG105776A
Other languages
Bulgarian (bg)
English (en)
Inventor
Valeria Szell
Ildiko Lang
Istvan Barta
Aniko Tegdes
Karoly Albrecht
Juliana SUTO
Istvan Szabo
Magdolna Petroczki
Janos Erdei
Eva Gulyas
Gabor Balogh
Original Assignee
Biogal Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar Rt. filed Critical Biogal Gyogyszergyar Rt.
Publication of BG105776A publication Critical patent/BG105776A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BG105776A 1999-02-03 2001-08-03 Microbiological method for the preparation of pseudomonic acid a antibiotic BG105776A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11845799P 1999-02-03 1999-02-03
US13733499P 1999-06-03 1999-06-03
PCT/US2000/002880 WO2000046389A1 (en) 1999-02-03 2000-02-03 Process for the preparation of pseudomonic acid a antibiotic by microbiological method

Publications (1)

Publication Number Publication Date
BG105776A true BG105776A (en) 2002-05-31

Family

ID=26816383

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105776A BG105776A (en) 1999-02-03 2001-08-03 Microbiological method for the preparation of pseudomonic acid a antibiotic

Country Status (22)

Country Link
US (3) US6509177B1 (xx)
EP (1) EP1151131A4 (xx)
JP (1) JP2003515311A (xx)
KR (1) KR20010113674A (xx)
CN (2) CN1203184C (xx)
AU (1) AU762768B2 (xx)
BG (1) BG105776A (xx)
BR (1) BR0009179A (xx)
CA (1) CA2360865A1 (xx)
CZ (1) CZ20012724A3 (xx)
HK (1) HK1041903A1 (xx)
HR (1) HRP20010576A2 (xx)
HU (1) HUP0300363A2 (xx)
IL (2) IL144679A0 (xx)
IS (1) IS6028A (xx)
MX (1) MXPA01007806A (xx)
NO (1) NO20013791L (xx)
PL (1) PL358615A1 (xx)
SK (1) SK10892001A3 (xx)
TR (1) TR200102234T2 (xx)
WO (1) WO2000046389A1 (xx)
YU (1) YU55601A (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012724A3 (cs) 1999-02-03 2001-12-12 Biogal Gyogyszergyar Rt Způsob přípravy antibiotické pseudomonové kyseliny A mikrobiologickou cestou
PL374255A1 (en) 2001-06-21 2005-10-03 Biogal Gyogyszergyar Rt Metabolic controlled fermentation process for pseudomonic acid production
HUP0600679A2 (en) 2001-12-28 2008-06-30 Biogal Gyogyszergyar Processes for preparing crystalline and amorphous mupirocin calcium and pharmaceutical compositions containing the same
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
ES2339682T3 (es) 2004-06-01 2010-05-24 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Procedimiento para la preparacion de la forma amorfa de un farmaco.
US7619102B2 (en) 2005-02-21 2009-11-17 Axellia Pharmaceuticals Aps Purification of mupirocin
WO2009117310A2 (en) * 2008-03-17 2009-09-24 Cedars-Sinai Medical Center Methods for treatment and prevention of mrsa/mssa
CN104370896A (zh) * 2013-11-29 2015-02-25 江苏汉邦科技有限公司 一种纯化假单孢菌素的方法
CN103820369B (zh) * 2014-03-07 2015-11-18 浙江瑞邦药业有限公司 一种萤光假单胞菌及其应用
CN108277243B (zh) * 2018-01-19 2021-03-12 浙江瑞邦药业股份有限公司 一种假单胞菌酸a的制备方法
CN108949845B (zh) * 2018-08-08 2021-08-10 福建康鸿生物科技有限公司 一种发酵培养基及由发酵培养基制备莫匹罗星的方法
EP4273256A1 (en) 2021-02-07 2023-11-08 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Fermentation method for mupirocin

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643240A1 (de) 1966-09-16 1971-06-24 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane
US3977943A (en) 1971-06-12 1976-08-31 Beecham Group Limited Antibiotics
US4071536A (en) 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1395907A (en) 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
JPS5270083A (en) * 1975-12-04 1977-06-10 Yoshitomi Pharmaceut Ind Ltd Manufacture of an antibiotics, trans-pseudomonic acid
GB1577730A (en) 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1103264A (en) 1977-09-30 1981-06-16 Norman H. Rogers Purification of pseudomonic acid
CA1115699A (en) 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
CA1196284A (en) 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8415579D0 (en) 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8428952D0 (en) 1984-11-16 1984-12-27 Beecham Group Plc Formulations
GB8530796D0 (en) 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
IN171883B (xx) 1990-07-27 1993-01-30 Hoechst India
US5594026A (en) 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
US5292892A (en) 1991-05-07 1994-03-08 Sankyo Company, Limited Anti-bacterial compound and pharmaceutical compositions thereof
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
AU724070B2 (en) 1996-10-01 2000-09-14 Smithkline Beecham Corporation Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
CN1345377A (zh) 1999-02-03 2002-04-17 拜奥盖尔药厂有限公司 从含假单胞菌酸复合体的培养液中分离假单胞菌酸a的方法
CZ20012724A3 (cs) 1999-02-03 2001-12-12 Biogal Gyogyszergyar Rt Způsob přípravy antibiotické pseudomonové kyseliny A mikrobiologickou cestou
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US6528086B2 (en) 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
IL137363A (en) 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate

Also Published As

Publication number Publication date
IS6028A (is) 2001-07-31
US6509177B1 (en) 2003-01-21
YU55601A (sh) 2003-02-28
IL144679A0 (en) 2002-06-30
US7078223B2 (en) 2006-07-18
PL358615A1 (en) 2004-08-09
BR0009179A (pt) 2001-11-27
SK10892001A3 (sk) 2002-06-04
IL144679A (en) 2007-06-17
US20030100083A1 (en) 2003-05-29
NO20013791D0 (no) 2001-08-02
CN1670217A (zh) 2005-09-21
EP1151131A1 (en) 2001-11-07
CZ20012724A3 (cs) 2001-12-12
AU2980800A (en) 2000-08-25
CN1203184C (zh) 2005-05-25
JP2003515311A (ja) 2003-05-07
KR20010113674A (ko) 2001-12-28
HK1041903A1 (zh) 2002-07-26
MXPA01007806A (es) 2003-06-04
US6506591B2 (en) 2003-01-14
WO2000046389A1 (en) 2000-08-10
WO2000046389A9 (en) 2001-09-07
CA2360865A1 (en) 2000-08-10
NO20013791L (no) 2001-10-02
HRP20010576A2 (en) 2002-08-31
HUP0300363A2 (hu) 2004-06-28
US20020042103A1 (en) 2002-04-11
EP1151131A4 (en) 2004-05-12
CN1354798A (zh) 2002-06-19
AU762768B2 (en) 2003-07-03
TR200102234T2 (tr) 2002-10-21

Similar Documents

Publication Publication Date Title
BG105776A (en) Microbiological method for the preparation of pseudomonic acid a antibiotic
AU2001292304A1 (en) Production process of surfactin
Tanida et al. Ansamitocins, maytansinoid antitumor antibiotics producing organism, fermentation, and antimicrobial activities
IL148762A (en) Preparation of 1,3- propanediol by fermentaiton of glycerol
FI86889B (fi) Foerfarande foer framstaellning av l-karnitin pao mikrobiologiskt saett.
HU9501951D0 (en) A process for producing immunosuppressives and a novel microbial species to be employed therein
AU1466999A (en) Bacterium capable of biodegradation of wastes
MY113838A (en) Process for production of amide compounds using microorganism
AU1539695A (en) Bacterial strains of genus (bacillus) closely phenotypically related to genus (lactobacillus), culture method and use
Takahashi et al. Production of (S, S)-Ethylenediamine-N, N′-disuccinic Acid from Ethylenediamine and Fumaric Acid by Bacteria.
KR102085764B1 (ko) 식물 생장 촉진 및 식물병 방제 활성을 갖는 슈도모나스 플레코글로시시다 ang14 균주 및 이의 용도
KR102097042B1 (ko) 식물 생장 촉진 및 식물병 방제 활성을 갖는 슈다스로박터 에퀴 ang28 균주 및 이의 용도
Imada et al. A novel marine Bacillus with multiple amino acid analog resistance and selenomethionine-dependent antibiotic productivity
CA1336414C (en) D-amidase and process for producing d-–-alanine and/or l-–-alanineamide
US5270203A (en) Biologically pure culture of Alcaligenes faecalis DSM 6335
WO1998037038A3 (de) Methode der stickstoffbindung aus der luft, mobilisation der phosphorverbindungen und der zersetzung des ölsedimentes
US5264361A (en) Microbiological process for the production of 6-hydroxypicolinic acid
DE3161317D1 (en) Process for the production of glucose dehydrogenase and microorganisms suitable therefor
JP4197778B2 (ja) 光学活性なα−メルカプトカルボン酸の製造方法
JP3873512B2 (ja) Ｄ−３−（２−ナフチル）アラニンの製造方法
Hong et al. A 3, 5-diaminohexanoate-decomposing Brevibacterium
JP2857936B2 (ja) 光学活性なα−メチルベンジルアミンの製造法
KR100392853B1 (en) Culture medium of microorganisms containing apricot seeds
Blank Enzymatic inactivation of residual gentamicin after membrane filtration
Mishra et al. Effect of phosphorus and boron conpounds on the production of cephalosporin- C acylase by two strains of bacteria